Novo Nordisk

Digital health round-up – health innovations shine at CES 2017

https://pharmaphorum.com/views-and-analysis/digital-health-round-health-innovations-shine-ces-2017/

Roche’s haemophilia drug hits phase 3 targets

https://pharmaphorum.com/news/roches-haemophilia-drug-hits-phase-3-targets/

Lilly and Boehringer biosimilar undercuts Lantus by 15%

https://pharmaphorum.com/news/lillyboehringer-to-undercut-sanofi-by-15-with-lantus-copycat/

“I’m going to bring down drug prices” – Trump

https://pharmaphorum.com/news/will-bring-drug-prices-trump/

Cost the barrier, but Novo not giving up on insulin pill, says CEO

https://pharmaphorum.com/news/novo-shelving-insulin-pill-ceo/

The ‘game changers’ in diabetes: Novo and Lilly battle it out

https://pharmaphorum.com/views-and-analysis/diabetes-drugs-prevent-heart-attacks-strokes-novo-lilly-battle/

Novo’s next-gen diabetes drug could be best at cutting heart attacks

https://pharmaphorum.com/news/novos-semaglutide-reduces-cv-events-diabetes/

Sanofi and Novo battle it out with diabetes combinations

https://pharmaphorum.com/news/sanofi-novo-battle-diabetes-combinations/

Novo Nordisk CEO Sorensen to retire

https://pharmaphorum.com/news/sorensen-step-novo-nordisk-ceo/

«< 9 10 11 12 13 >

Close in 10 seconds

Pharmaphorum.com

Search